These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6194253)

  • 21. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.
    Leyland-Jones B; Donnelly H; Groshen S; Myskowski P; Donner AL; Fanucchi M; Fox J
    J Infect Dis; 1986 Sep; 154(3):430-6. PubMed ID: 3525694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Virostatic therapy with adenine arabinoside].
    Werner TG
    Med Klin; 1978 Oct; 73(43):2. PubMed ID: 82198
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans.
    Whitley RJ; Tucker BC; Kinkel AW; Barton NH; Pass RF; Whelchel JD; Cobbs CG; Diethelm AG; Buchanan RA
    Antimicrob Agents Chemother; 1980 Nov; 18(5):709-15. PubMed ID: 6160811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study.
    Whitley RJ; Ch'ien LT; Dolin R; Galasso GJ; Alford CA
    N Engl J Med; 1976 May; 294(22):1193-9. PubMed ID: 177866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
    Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
    JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
    Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
    Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic hepatitis B and adenine arabinoside monophosphate (Ara-AMP).
    Novick DM
    Ann Intern Med; 1988 Mar; 108(3):492-3. PubMed ID: 2449111
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
    Garcia G; Smedile A; Bergmann KF; Gerin JL; Gregory PB; Merigan TC; Robinson WS
    West J Med; 1990 Jul; 153(1):80-2. PubMed ID: 1697132
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
    Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
    Weller IV
    J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
    Hoofnagle JH; Davis GL; Hanson RG; Pappas SC; Peters MG; Avigan MI; Waggoner JG; Howard R; Jones EA; Straus SE
    J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
    Weller IV; Lok AS; Mindel A; Karayiannis P; Galpin S; Monjardino J; Sherlock S; Thomas HC
    Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Suppression of bone marrow in neonatal herpes simplex virus infection under virustatic therapy with adenine arabinoside-5'-monophosphate (author's transl)].
    Ebell W; Borchard F; Knoll G; von Voss H
    Klin Padiatr; 1980 Nov; 192(6):582-6. PubMed ID: 6163882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vidarabine encephalopathy.
    Cullis PA; Cushing R
    J Neurol Neurosurg Psychiatry; 1984 Dec; 47(12):1351-4. PubMed ID: 6512557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study.
    Ch'ien LT; Whitley RJ; Alford CA; Galasso GJ
    J Infect Dis; 1976 Jun; 133 Suppl():A184-91. PubMed ID: 180198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine.
    McCann WP; Hall LM; Siler W; Barton N; Whitley RJ
    Antimicrob Agents Chemother; 1985 Aug; 28(2):265-73. PubMed ID: 2423028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of herpes simplex virus encephalitis in mice by direct intracerebral injection.
    Cameron KR; Adams DH
    J Infect Dis; 1979 Dec; 140(6):921-6. PubMed ID: 94338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
    Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.